European VCs form coalition to get more support for biotech investingnews2026-02-12T10:00:29+00:00February 12th, 2026|Endpoints News|
Updated: Sanofi’s Paul Hudson out, with Belén Garijo to step in as new CEOnews2026-02-12T07:11:12+00:00February 12th, 2026|Endpoints News|
Hinge Health is looking to build AI tools for mental health supportnews2026-02-12T02:14:33+00:00February 12th, 2026|Endpoints News|
FDA may consider Moderna’s flu vaccine in a narrower groupnews2026-02-11T21:06:04+00:00February 11th, 2026|Endpoints News|
Former AstraZeneca senior staff charged with illegal trade in Chinanews2026-02-11T20:24:40+00:00February 11th, 2026|Endpoints News|
Prasad overruled vaccine review team, office director on Moderna flu shotnews2026-02-11T16:21:58+00:00February 11th, 2026|Endpoints News|
After CEO departs, CSL details profit crash, $1.1B impairment costs news2026-02-11T16:18:10+00:00February 11th, 2026|Endpoints News|
Madrigal pads MASH pipeline with six siRNAs from China’s Ribonews2026-02-11T15:49:41+00:00February 11th, 2026|Endpoints News|
Gubra forms venture unit; Galecto’s $275M offeringnews2026-02-11T15:02:48+00:00February 11th, 2026|Endpoints News|
How a closet full of EKG machines illustrates pharma’s clinical trial cost problemnews2026-02-11T15:00:30+00:00February 11th, 2026|Endpoints News|
